Article
Myeloperoxidase G463A polymorphism and risk of lung cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 1 Jan 2014
Li Junrui, Fu Yingju, Zhao Baochun, Xiao Ying, Chen Ruiying
Abstract excerpt
Myeloperoxidase (MPO) is a phase I enzyme playing a crucial role in metabolically activating a wide range of procarcinogens, such as polycyclic aromatic hydrocarbons and aromatic amines. The G463A polymorphism in the promoter region of the MPO gene has been indicated in lung cancer risk. To investigate the precise association of MPO G463A polymorphism with the lung cancer risk, we performed this comprehensive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
